Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML (Oct, 10.1038/s41409-021-01393-9, 2021)

Krieger Elizabeth; Qayyum Rehan; Keating ArmandToor Amir

首页> 外文期刊>Bone marrow transplantation >Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML (Oct, 10.1038/s41409-021-01393-9, 2021)

【24h】

Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML (Oct, 10.1038/s41409-021-01393-9, 2021)

机译：Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML (Oct, 10.1038/s41409-021-01393-9, 2021)

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相关主题

著录项

来源
《Bone marrow transplantation》 |2021年第11期|2871-2871|共1页
作者
Krieger Elizabeth; Qayyum Rehan; Keating ArmandToor Amir;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类治疗学;
关键词

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号

Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML (Oct, 10.1038/s41409-021-01393-9, 2021)

著录项

相关主题

期刊订阅